NDC 68382-659

pyridostigmine bromide

Pyridostigmine Bromide

pyridostigmine bromide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Zydus Pharmaceuticals (usa) Inc.. The primary component is Pyridostigmine Bromide.

Product ID68382-659_70ca32f1-d6ca-43d7-9dde-0925a9549dca
NDC68382-659
Product TypeHuman Prescription Drug
Proprietary Namepyridostigmine bromide
Generic NamePyridostigmine Bromide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-08-07
Marketing CategoryANDA / ANDA
Application NumberANDA205650
Labeler NameZydus Pharmaceuticals (USA) Inc.
Substance NamePYRIDOSTIGMINE BROMIDE
Active Ingredient Strength60 mg/1
Pharm ClassesCholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 68382-659-01

100 TABLET in 1 BOTTLE (68382-659-01)
Marketing Start Date2015-08-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68382-659-05 [68382065905]

pyridostigmine bromide TABLET
Marketing CategoryANDA
Application NumberANDA205650
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-08-07

NDC 68382-659-01 [68382065901]

pyridostigmine bromide TABLET
Marketing CategoryANDA
Application NumberANDA205650
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-08-07

NDC 68382-659-16 [68382065916]

pyridostigmine bromide TABLET
Marketing CategoryANDA
Application NumberANDA205650
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-08-07

NDC 68382-659-06 [68382065906]

pyridostigmine bromide TABLET
Marketing CategoryANDA
Application NumberANDA205650
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-08-07

Drug Details

Active Ingredients

IngredientStrength
PYRIDOSTIGMINE BROMIDE60 mg/1

OpenFDA Data

SPL SET ID:44e8c2dd-3931-4508-9fa7-5a660d6dfddb
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 903857
  • Pharmacological Class

    • Cholinesterase Inhibitor [EPC]
    • Cholinesterase Inhibitors [MoA]

    Medicade Reported Pricing

    68382065906 PYRIDOSTIGMINE BR 60 MG TABLET

    Pricing Unit: EA | Drug Type:

    68382065901 PYRIDOSTIGMINE BR 60 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "pyridostigmine bromide" or generic name "Pyridostigmine Bromide"

    NDCBrand NameGeneric Name
    0115-1404Pyridostigmine BromidePYRIDOSTIGMINE BROMIDE
    0115-2134Pyridostigmine BromidePYRIDOSTIGMINE BROMIDE
    0115-3511Pyridostigmine BromidePYRIDOSTIGMINE BROMIDE
    0904-6622pyridostigmine bromidepyridostigmine bromide
    47781-335Pyridostigmine BromidePyridostigmine Bromide
    68084-494Pyridostigmine BromidePyridostigmine Bromide
    68382-659pyridostigmine bromidepyridostigmine bromide
    68682-302Pyridostigmine BromidePyridostigmine Bromide
    68682-301pyridostigmine bromidepyridostigmine bromide
    72458-128Pyridostigmine BromidePyridostigmine Bromide
    64980-220Pyridostigmine BromidePyridostigmine Bromide
    65841-819pyridostigmine bromidepyridostigmine bromide
    71930-028Pyridostigmine BromidePyridostigmine Bromide
    58657-810Pyridostigmine BromidePyridostigmine Bromide
    68682-307pyridostigmine bromidepyridostigmine bromide
    50268-638Pyridostigmine BromidePyridostigmine Bromide
    68071-5032Pyridostigmine BromidePyridostigmine Bromide
    60687-502Pyridostigmine BromidePyridostigmine Bromide
    63739-969Pyridostigmine BromidePyridostigmine Bromide
    65084-999Pyridostigmine BromidePyridostigmine Bromide
    66689-406Pyridostigmine BromidePyridostigmine Bromide
    69238-1731Pyridostigmine BromidePyridostigmine Bromide
    0187-3010Mestinonpyridostigmine bromide
    0187-3012Mestinonpyridostigmine bromide
    0187-3013Mestinonpyridostigmine bromide
    13811-716Pryidostigmine BromidePyridostigmine Bromide
    16571-833Pryidostigmine BromidePyridostigmine Bromide
    24689-104PRYIDOSTIGMINE BROMIDEpyridostigmine bromide
    0781-3040RegonolPyridostigmine Bromide

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.